Patents
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
06/2000
06/29/2000WO2000037436A1 Sulfonamide hydroxamates
06/29/2000WO2000037429A2 INHIBITORS OF α4β1 MEDIATED CELL ADHESION
06/29/2000WO2000037423A1 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
06/29/2000WO2000037035A1 Deodorizing cosmetic agents
06/29/2000WO2000002887A3 Ligands for metals and metal-catalyzed processes
06/29/2000DE19859684A1 Verfahren zur Herstellung von Fluor enthaltenden Phenethylaminen sowie neue, Fluor enthalende beta-Iminovinyl- und beta-Iminoethylbenzole A process for preparing fluorine-containing phenethylamines and new, fluorine enthalende beta-iminovinyl- and beta-iminoethylbenzenes
06/29/2000DE19858812A1 Desodorierende kosmetische Mittel Deodorizing cosmetic products
06/29/2000CA2355902A1 Sulfonamide hydroxamates
06/28/2000EP1013637A2 Process for the preparation of fluor containing phenethylamines and fluor containing beta-iminovinyl- and beta-iminoethylphenyl compounds
06/28/2000EP1012131A1 Enantioselective reduction of ketones with a silane agent/metal compound/chiral ligand system
06/28/2000CN1258291A Polymerisable, optically active dioxolane diesters
06/28/2000CN1257857A Tetrahydronaphthalenes, their preparing method and use
06/27/2000US6080862 Preparing (1s, 2r, 3s)-3-(2-hydroxyeth-1-yloxy)-4-methoxyphenyl) 1-(3,4-methylenedioxyphenyl) 5-(prop-1-yloxy)indane-2-carboxylic acid
06/27/2000US6080781 Dissolving tetralone or benzopyranone compounds and a benzaldehyde compound in organic solvent, refluxing with heating under acidic condition and purifying the reactio product; useful for treating hormone dependent disease
06/27/2000US6080767 Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
06/27/2000CA2110748C Process for the preparation of vitamin a and intermediate compounds useful in the process
06/23/2000CA2292851A1 Process for preparing fluorine-containing phenethylamines and novel fluorine-containing .beta.-iminovinyl-and .beta.-iminoethylbenzenes
06/22/2000WO2000035858A1 Phenylglycine derivatives
06/22/2000WO2000035835A1 Process for the preparation of organic compounds with imide catalysts
06/21/2000EP1010688A1 Substituted 2-phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
06/21/2000EP1010685A1 New tetrahydronaphthalenes
06/21/2000EP0785196B1 Polymorphs a and b of 1-(diphenylmethyl)-4-[3-(2-phenyl-1,3-dioxolan-2-yl) propyl]piperazine
06/21/2000CN1053665C 2,4-diaryl-1,3-dithiolanes, 2,4-diaryl-1,3-dioxolanes, 2,4-diaryl-1,3-oxathiolanes derivant
06/21/2000CN1053657C Didepside phthaleins based internal parasite compositions, novel didepside phthaleins and preparation process thereof
06/20/2000US6077850 Useful for treating cyclooxygenase-2 mediated disorders, such as inflammation and inflammation-related disorders
06/15/2000WO2000034237A2 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
06/15/2000CA2350899A1 Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses
06/15/2000CA2292193A1 Tetra-hydronaphthalenes
06/14/2000EP1008592A2 Cyclic amide derivatives which inhibit cathepsin K
06/14/2000EP1008346A1 NF-$g(k)B INHIBITORS CONTAINING AS THE ACTIVE INGREDIENT PHENYLMETHYL BENZOQUINONE
06/14/2000EP0871606B1 New compounds and their compositions having anti-inflammatory and anti-thrombotic activities
06/14/2000EP0777645B1 Oxime ethers and their use as pesticides
06/14/2000EP0710223B1 Synthesis of taxol and its derivatives
06/13/2000US6075166 Solid phase synthesis of amines; as a sequential encoding, or a tagging agent
06/08/2000WO2000032552A1 Process for the preparation of functionalized chiral cyclopentanes involving transformation of azanorbornyl derivatives
06/07/2000EP1005448A2 Novel inhibitors of aggrecanase and matrix metalloproteinases for the treatment of arthritis
06/07/2000EP1005446A1 N-aroylphenylalanine derivatives
06/07/2000CN1255653A Cross linking agent for photoslushing compound, and photoslushing compound compsns. containing same cross linking agent
06/06/2000US6072062 Synthesis of C18 -modified vitamin D compounds and compounds resulting therefrom
06/06/2000US6071861 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production
06/06/2000US6071510 Modified amino acids and compositions comprising the same for delivering active agents
05/2000
05/31/2000EP1003731A1 Process for the manufacture of epoxy compounds
05/31/2000EP1003714A1 Aromatic amides, their preparation process and their use as pesticides
05/31/2000EP1003706A1 Cyclohexenone long-chain alcohol and medicament containing same
05/31/2000EP1003493A1 Use of selective rxr agonists to prevent surgical adhesions
05/31/2000EP0794942B1 Substituted biphenyl compounds for the treatment of inflammation
05/31/2000DE19956532A1 Vernetzer für ein Photoresist und diesen enthaltende Photoresistzusammensetzung Crosslinkers for photoresist and photoresist composition containing it
05/31/2000CN1255123A Process for covalently coupling organic compounds utilizing diboron derivatives
05/31/2000CN1255115A Substituted 2-(3-alkenyl-benzoyl)-cyclohexane-1,3-diones
05/31/2000CN1254596A Process for preparing composition to kill internal parasites
05/30/2000US6069283 Illudin analogs useful as antitumor agents
05/30/2000US6069258 Cosmetic preparations comprising photostable UV-A filters
05/30/2000US6069250 Method and compositions for the synthesis of dioxolane nucleosides with β-configuration
05/30/2000US6069176 Phenylethanolamine compounds with a beta-3 adrenergic receptor stimulating effect, use as a therapy for urinary incontinence
05/24/2000EP0931083A4 Process for producing ecteinascidin compounds
05/24/2000CN1254337A N-hydroxy 4-sulfonyl butyramide compounds
05/23/2000US6066642 For selectively blocking the a3 adenosine receptor of a mammal
05/18/2000WO2000027853A1 Hydroboronation process
05/18/2000WO2000027838A1 Method for producing monohalogenated 2-oxo-1,3-dioxolanes using azobisisobutyronitrile
05/18/2000WO2000027837A1 Method for producing monohalogenated 2-oxo-1,3-dioxolanes
05/18/2000WO2000027805A1 Substituted 3,3-diamino-2-propenenitriles, their preparation and use
05/18/2000WO2000027800A1 Ccr-3 receptor antagonists
05/18/2000WO2000027786A1 Stereoselective process for preparing (cyclo)alkyl phenylglycolic acids
05/18/2000WO2000007979A3 Compounds and compositions for delivering active agents
05/18/2000CA2349209A1 Stereoselective process for preparing (cyclo)alkyl phenylglycolic acids
05/18/2000CA2349194A1 Process for the preparation of monohalogenated 2-oxo-1,3-dioxolanes
05/18/2000CA2348486A1 Hydroboronation process
05/17/2000EP1000934A2 Pesticidal and parasiticidal use of 1-aryl-1-(substituted thio, sulfinyl and sulfonyl)-2-nitroethane compounds
05/17/2000EP1000619A2 Method for treating glaucoma
05/17/2000EP1000035A1 Substituted 6-phenylphenanthridines
05/17/2000EP1000029A1 (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders
05/17/2000EP1000018A2 Urokinase inhibitors
05/17/2000EP0781270B1 Ring-opening amidation process
05/17/2000CN1253559A Sulfonyl divalent aryl alpha-hydroxamic acid compounds
05/17/2000CN1253474A Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
05/17/2000CN1253019A Method for preparing medicine composition capable of inhibiting post infective virus proteinase
05/16/2000CA2289827A1 Pesticidal and parasiticidal use of 1-aryl-1-(substituted thio, sulfinyl and sulfonyl)-2-nitroethane
05/11/2000WO2000026323A1 Electrolumiscent materials
05/11/2000WO2000025776A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
05/11/2000WO2000025770A1 Carbocyclic potassium channel inhibitors
05/11/2000DE19912359A1 Verfahren zur Herstellung von monohalogenierten 2-Oxo-1,3-dioxolanen mit Azobisisobutyronitril A process for preparing monohalogenated 2-oxo-1,3-dioxolanes with azobisisobutyronitrile
05/11/2000CA2348878A1 Electroluminescent materials
05/10/2000EP0998278A1 Hydroxy and ether-containing oxyalkylene esters and uses thereof
05/10/2000CN1252799A N-heterocyclic derivatives as NOS inhibitor
05/10/2000CN1252690A Fungicide active substance combinations
05/10/2000CN1052240C Method for preparing inhibitor of retroinfection viral protease
05/09/2000US6060506 Benzopyran derivatives as melatonergic agents
05/09/2000US6060493 Phenyl benzyl ethers, process for producing them and their use as pesticide and fungicide
05/09/2000US6060476 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
05/04/2000WO2000025381A1 Non-aqueous electrolyte for electrochemical systems and lithium secondary battery comprising the same
05/03/2000EP0996439A1 $g(b)-ALKOXYACRYLATES AGAINST MALARIA
05/03/2000EP0996434A1 Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
05/03/2000EP0873289B1 Process for catalytic addition of nucleophiles to alkines or allenes
05/03/2000CN1052001C Preparation of astaxanthin and intermediate thereof
05/02/2000US6057459 Dehydration to form alkene
05/02/2000US6057371 Sigma receptor ligands and the use thereof
05/02/2000US6057369 Use in the treatment of disease states associated with proteins that mediate cellular activity which are capable of being modulated by inhibiting a matrix metalloproteinase (mmp), tumor necrosis factor (tnf) or cyclic amp
05/02/2000CA2000179C Cyclopenteneheptenoic acid derivatives and method of preparation thereof
04/2000
04/27/2000WO2000023433A1 Substituted benzopyran analogs for the treatment of inflammation
04/27/2000WO2000023432A1 Therapeutic compounds and methods